Feedback / Questions
ITM-91 - 3B Pharma, ITM Isotopen Technologien Munchen
https://www.globenewswire.com/news-release/2024/09/12/2944984/0/en/ITM-Obtains-Exclusive-Worldwide-License-from-Debiopharm-for-CA-IX-Targeted-Peptide-based-Radiopharmaceutical-Programs-Targeting-Solid-Tumors.html
Sep 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next